HomeVXL • CVE
add
Vaxil Bio Ltd
Previous close
$0.010
Year range
$0.0050 - $0.035
Market cap
1.37M CAD
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 58.00K | -53.60% |
Net income | -58.00K | 53.60% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 920.00K | -31.45% |
Total assets | 933.00K | -31.60% |
Total liabilities | 98.00K | -72.24% |
Total equity | 835.00K | — |
Shares outstanding | 136.98M | — |
Price to book | 1.00 | — |
Return on assets | -15.19% | — |
Return on capital | -16.80% | — |
Cash Flow
Net change in cash
(CAD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -58.00K | 53.60% |
Cash from operations | -20.00K | 87.80% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -18.00K | 89.29% |
Free cash flow | 4.75K | 104.09% |
About
Founded
2006
Headquarters
Website